BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.2460
-0.0093 (-3.64%)
At close: Sep 18, 2026
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of $39.82 million as of September 18, 2026. Its market cap has increased by 307.90% in one year.
Market Cap
39.82M
Enterprise Value
42.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
ChartMarket Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 98.33M to 39.82M, a decrease of -59.50%. That is a compound annual growth rate of -5.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 39.82M | 711.70% |
| Dec 31, 2025 | 4.91M | -47.43% |
| Dec 31, 2024 | 9.33M | 68.00% |
| Dec 29, 2023 | 5.55M | -49.28% |
| Dec 30, 2022 | 10.95M | -24.42% |
| Dec 31, 2021 | 14.49M | -81.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 70.69M |
| Nuo Therapeutics | 62.96M |
| Sangamo Therapeutics | 60.03M |
| Arch Biopartners | 40.43M |
| Cell Source | 33.97M |
| ProText Mobility | 31.21M |
| Vicapsys Life Sciences | 27.52M |
| Zenith Capital | 24.17M |